论文部分内容阅读
目的探讨阿莫西林、克拉霉素及雷贝拉唑联合治疗胃溃疡的临床效果。方法选取2012年12月至2015年12月收治的胃溃疡患者120例,按照随机数字表法随机分成观察组和对照组,每组60例。对照组采用阿莫西林、克拉霉素及奥美拉唑进行联合治疗,观察组采用阿莫西林、克拉霉素及雷贝拉唑进行联合治疗,最后对两组患者的腹痛好转时间、好转率、临床疗效及不良反应等进行观察和比较分析。结果治疗后,治疗组治疗总有效率(96.67%)远高于对照组(86.67%),组间比较差异有统计学意义(P<0.05)。在治疗过程中,治疗组不良反应发生率明显低于对照组,组间比较差异有统计学意义(P<0.05)。结论阿莫西林、克拉霉素及雷贝拉唑联合治疗胃溃疡患者疗效确切,能够缩短患者的腹痛时间,提高腹痛好转率及临床疗效,安全性较高,进而能够有效加快患者的康复,值得临床推广。
Objective To investigate the clinical effects of amoxicillin, clarithromycin and rabeprazole in the treatment of gastric ulcer. Methods 120 patients with gastric ulcer admitted from December 2012 to December 2015 were randomly divided into observation group and control group according to the random number table method, with 60 cases in each group. The control group was treated with amoxicillin, clarithromycin and omeprazole. The observation group was treated with amoxicillin, clarithromycin, and rabeprazole. Finally, the improvement of abdominal pain time, improvement rate , Clinical efficacy and adverse reactions were observed and compared. Results After treatment, the total effective rate of the treatment group (96.67%) was much higher than that of the control group (86.67%). There was significant difference between the two groups (P <0.05). During the treatment, the incidence of adverse reactions in the treatment group was significantly lower than that in the control group, the difference was statistically significant (P <0.05). Conclusion Amoxicillin, clarithromycin and rabeprazole combined treatment of gastric ulcer patients exact effect, can reduce the patient’s abdominal pain time, improve the rate of abdominal pain and improve the clinical efficacy, safety, and thus be able to effectively speed up the recovery of patients, it is worth Clinical promotion.